Journal
ARTHRITIS RESEARCH & THERAPY
Volume 10, Issue 3, Pages -Publisher
BMC
DOI: 10.1186/ar2417
Keywords
-
Categories
Funding
- NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR055989, P60AR047782] Funding Source: NIH RePORTER
- NIAMS NIH HHS [P60 AR047782, AR 047782, AR055989, K24 AR055989] Funding Source: Medline
Ask authors/readers for more resources
The association between rheumatoid arthritis (RA) and malignancies has received increased attention in recent years. Reports suggesting that tumor necrosis factor blockers might elevate the risk of malignancy in RA patients have prompted researchers to look at the incidence of malignancies in all RA patients. In a recent issue of Arthritis Research & Therapy, Smitten and colleagues suggest that previous reports of a standardized incidence ratio close to one for malignancies in RA may reflect an increased risk for some site-specific malignancies and a reduced risk for others. Here we discuss these findings and suggest what issues could be addressed in future studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available